Market Currents
Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that...
-
Thursday, April 12, 2012, 12:30 PM ETRegeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that Roche's (RHHBY.PK +2.5%) Lucentis market share is declining, and the number of patients switching to Eylea from other treatments is accelerating. The firm maintains an Outperform rating on the stock.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
